Octreotide-Induced Bradycardia and Heart Block during Surgical Resection of a Carcinoid Tumor

John A. Dilger, Edwin H. Rho, Florencia G. Que, Juraj Sprung

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Octreotide may be a life-saving treatment in the case of an acute carcinoid crisis, but when given as an IV bolus in larger doses, it may cause significant effects on the cardiac conduction system. We describe cardiac conduction impairment observed during octreotide administration in a patient undergoing carcinoid tumor surgery. In this patient, IV boluses of 100 μg of octreotide resulted in symptomatic bradycardia, Mobitz type II atrioventricular block, and complete heart block. Perioperative physicians especially need to be aware of these potential effects because they may be more likely to occur during surgery because of the larger doses and boluses that are used to treat acute symptoms secondary to tumor manipulation.

Original languageEnglish (US)
Pages (from-to)318-320
Number of pages3
JournalAnesthesia and analgesia
Volume98
Issue number2
DOIs
StatePublished - Feb 2004

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Octreotide-Induced Bradycardia and Heart Block during Surgical Resection of a Carcinoid Tumor'. Together they form a unique fingerprint.

Cite this